Business
Warren Buffett’s $7.8b pharma bet – The Australian Financial Review
The investment in drugmakers by “the Oracle of Omaha” will be closely scrutinised by Wall Street.
The four new purchases more than doubled the size of Berkshires investments in healthcare stocks in the third quarter to $US9.3 billion in total. The company already held stakes in the drugmakers Biogen, Johnson & Johnson and Teva Pharmaceuticals and DaVita, a kidney dialysis company.
Mr Buffett did not respond to a request for comment.
Berkshire cut its stake in several large banks during the three months to the end of September, including Wells Fargo, JPMorgan Chase, PNC Financial and M&T Bank….
-
Noosa News6 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News7 hours agoMotorcyclist dies in crash with truck
-
Noosa News21 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General21 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate